Great to see we are making progress on the trials. Looks like things are going to heat up next year, although I do expect this qtr will also surprise on the upside.
I don't like to respond to Piggy, don't feed the trolls, but his recent post is just a load of rubbish, as usual. Why would audiologists sell OTC products? The whole idea behind the legislation is to remove them from the equation to break the strangle hold the big 5 have in the market, so most won't. Some forward thinking organisations Like Specsavers and Boots may add them into the mix, to acquire the customer early on their hearing health journey.
Best buy is obviously positioning itself to be a key player in the OTC space and who did they choose?
HP will have the Dragonfly on sale in volume by early Feb, so expect we will see some orders this qtr as well.
We also still haven't seen an announcement about the NHS taking on the Max, unless I missed it, so that would have to be in the pipeline.
The app store for different hearing conditions has been quiet, hopefully that's still on the roadmap as well.
One good quality announcement, that has sales locked in, and this thing would look like the bargin of the century at these prices.
Looking forward to seeing the next 4C at the end of January
GLTA
- Forums
- ASX - By Stock
- Ann: Nuheara Clinical Trial and FDA 510(K) Pathway Update
Great to see we are making progress on the trials. Looks like...
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NUH (ASX) to my watchlist
(20min delay)
|
|||||
Last
8.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $21.75M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
NUH (ASX) Chart |
Day chart unavailable
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
Previous Video
Next Video
SPONSORED BY The Market Online